Washington — The Food and Drug Administration (FDA) has issued warnings to five firms — Triangle Compounding Pharmacy, University Pharmacy, Custom Scripts Pharmacy, Hal's Compounding Pharmacy and New England Compounding Center — in an effort to stop compounding and distributing standardized versions of topical anesthetic creams.
London — A British high court dealt Allergan a substantial blow recently when the court revoked the patent for Botox.
Dr. Grimes is encouraging physicians to submit their opinions to the FDA and to enlist the cooperation of their patients.
The impact of the systems is often to shock consumers.
Dr. Casas has begun to use two herbal agents with anti-inflammatory activity, arnica montana and bromelain, to reduce bruising and swelling in procedures involving muscle and soft tissue manipulation.
National report — Although the pharmaceutical industry and medical professional organizations have guidelines regarding physician relationships with industry, it is incumbent on individual professionals to apply those guidelines in such a way that they will maintain public trust and continue to serve their patients' best interests, says Stephen B. Webster, M.D., department of dermatology, Gundersen Lutheran Medical Center, La Crosse, Wis.
Washington -- The American Medical Association (AMA) is urging the government to force pharmaceutical companies to delay advertising of new prescription drugs directly to consumers until physicians have time to review and study the drugs for safety and effectiveness.
The American Board of Facial Plastic and Reconstructive Surgery (ABFPRS) announced that as of January 1, 2007, surgeons seeking initial certification by ABFPRS will need to operate an accredited facility when performing procedures using level II or greater anesthesia.
Chicago — Patients seeking full facial rejuvenation can now choose from an unprecedented array of nonsurgical options, according to William P. Werschler, M.D.